Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A

Summary

This study is to test whether the study drug (OBI-1) is safe and effective for the treatment of serious bleeding episodes in people with congenital hemophilia A.

Timeline

Start

2011-10-03

Primary completion

2013-07-29

Completion

2013-07-29

Drugs

Indications